226 related articles for article (PubMed ID: 11093887)
1. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
García-Ruiz JC; Pontón J
Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
[No Abstract] [Full Text] [Related]
2. [Mycoses and their treatment in malignant hemopathies].
Martino P; Girmenia C
Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
[TBL] [Abstract][Full Text] [Related]
3. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
Bow EJ
Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
[TBL] [Abstract][Full Text] [Related]
4. Antifungal therapy in 'bone marrow failure'.
Richardson MD; Kokki MH
Br J Haematol; 1998 Mar; 100(4):619-28. PubMed ID: 9531326
[No Abstract] [Full Text] [Related]
5. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.
Taçyildiz N; Yavuz G; Unal E; Gözdasoğlu S; Ertem M; Aysev D
Med Pediatr Oncol; 1999 Dec; 33(6):596-7. PubMed ID: 10573590
[No Abstract] [Full Text] [Related]
6. Fungal infections in nontransplant patients with hematologic malignancies.
Segal BH; Bow EJ; Menichetti F
Infect Dis Clin North Am; 2002 Dec; 16(4):935-64, vii. PubMed ID: 12512188
[TBL] [Abstract][Full Text] [Related]
7. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
Ruhnke M; Maschmeyer G
Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
[TBL] [Abstract][Full Text] [Related]
8. Fungal infections in immunocompromised patients.
Sganga G
Mycoses; 2011 Dec; 54 Suppl 4():1-3. PubMed ID: 22126521
[No Abstract] [Full Text] [Related]
9. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies.
Fukushima N; Mannen K; Okamoto S; Shinogi T; Nishimoto K; Sueoka E
Intern Med; 2005 Aug; 44(8):879-82. PubMed ID: 16157992
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Kurosawa M; Yonezumi M; Hashino S; Tanaka J; Nishio M; Kaneda M; Ota S; Koda K; Suzuki N; Yoshida M; Hirayama Y; Takimoto R; Torimoto Y; Mori A; Takahashi T; Iizuka S; Ishida T; Kobayashi R; Oda T; Sakai H; Yamamoto S; Takahashi F; Fukuhara T
Int J Hematol; 2012 Dec; 96(6):748-57. PubMed ID: 23111539
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal infections in paediatric patients.
Roilides E; Walsh TJ
Clin Microbiol Infect; 2010 Sep; 16(9):1319-20. PubMed ID: 20678174
[No Abstract] [Full Text] [Related]
13. [Trends of invasive fungal infections in hematological malignancies and new antifungal agents].
Mori T
Rinsho Ketsueki; 2003 Jan; 44(1):8-13. PubMed ID: 12649831
[No Abstract] [Full Text] [Related]
14. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008.
Slavin MA
Intern Med J; 2008 Jun; 38(6b):457-67. PubMed ID: 18588519
[TBL] [Abstract][Full Text] [Related]
15. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies.
Kataoka-Nishimura S; Akiyama H; Saku K; Kashiwa M; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
Cancer; 1998 Feb; 82(3):484-7. PubMed ID: 9452265
[TBL] [Abstract][Full Text] [Related]
16. Breakthrough invasive fungal infections: Who is at risk?
Jenks JD; Cornely OA; Chen SC; Thompson GR; Hoenigl M
Mycoses; 2020 Oct; 63(10):1021-1032. PubMed ID: 32744334
[TBL] [Abstract][Full Text] [Related]
17. Advances in the management of fungal infections.
Muñoz P; Valerio M; Vena A; Bouza E; Posteraro B; Lass-Flörl C; Sanguinetti M
Mycoses; 2015 Jun; 58 Suppl 2():1. PubMed ID: 26033250
[No Abstract] [Full Text] [Related]
18. [Prophylaxis of fungal infections in haematological patients: pro].
Glass B
Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
[No Abstract] [Full Text] [Related]
19. Management of systemic Fusarium infection in children with leukemia.
Ariffin H; Ariffin W; Mohamed M; Arasu A; Peng LH
Med Pediatr Oncol; 1999 Dec; 33(6):598-9. PubMed ID: 10573592
[No Abstract] [Full Text] [Related]
20. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
